Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2400082300Phase 4Not yet recruiting
Phase 4, open-label trial of dexmedetomidine, morphine, ropivacaine, lidocaine, magnesium sulfate and 3 more in postoperative pain (2 arms), sponsored by Zhongshan Hospital (Xiamen), Fudan University. Primary endpoint: QoR-15. Planned start Mar 2024; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2400082300.